BCL11A and triple-negative breast carcinoma: Bcl11a (B cell CLL/lymphoma 11A) is overexpressed in triple-negative breast cancer and plays critical roles in stem and progenitor cells 38; it was downregulated by i.v. Talazoparib and NanoTLZ.